See more : West Wits Mining Limited (WWI.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Alpha Healthcare Acquisition Corp. (AHAC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alpha Healthcare Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- TBS Holdings,Inc. (TKOBF) Income Statement Analysis – Financial Results
- Nevo Energy, Inc. (NEVE) Income Statement Analysis – Financial Results
- Noram Lithium Corp. (NRM.V) Income Statement Analysis – Financial Results
- Elmer Bancorp, Inc. (ELMA) Income Statement Analysis – Financial Results
- Monarca Minerals Inc. (ORAGF) Income Statement Analysis – Financial Results
Alpha Healthcare Acquisition Corp. (AHAC)
About Alpha Healthcare Acquisition Corp.
Alpha Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 0.00 | 1.57M | 1.26M | 1.49M | 6.19M |
Cost of Revenue | 76.55M | 8.26M | 49.00K | 8.43M | 75.60M |
Gross Profit | -76.55M | -6.69M | 1.21M | -6.94M | -69.42M |
Gross Profit Ratio | 0.00% | -427.48% | 96.12% | -465.53% | -1,121.97% |
Research & Development | 76.55M | 63.26M | 61.34M | 54.08M | 75.60M |
General & Administrative | 23.39M | 22.88M | 21.13M | 12.01M | 16.27M |
Selling & Marketing | -3.00M | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 20.39M | 22.88M | 21.13M | 12.01M | 16.27M |
Other Expenses | -73.44M | -1.57M | -1.26M | -1.49M | 0.00 |
Operating Expenses | 23.50M | 84.58M | 81.21M | 64.60M | 16.28M |
Cost & Expenses | 100.05M | 84.58M | 81.21M | 64.60M | 91.88M |
Interest Income | 0.00 | 2.63M | 16.00K | 278.00K | 269.00K |
Interest Expense | 1.13M | 6.20M | 4.35M | 2.20M | 2.30M |
Depreciation & Amortization | 7.72M | 8.26M | 8.28M | 8.43M | 6.75M |
EBITDA | -96.46M | 2.49M | -72.97M | -56.25M | -78.94M |
EBITDA Ratio | 0.00% | -10,245.69% | -10,845.61% | -3,753.92% | -1,275.93% |
Operating Income | -100.05M | -84.58M | -81.21M | -64.60M | -85.69M |
Operating Income Ratio | 0.00% | -5,404.35% | -6,429.77% | -4,332.66% | -1,385.02% |
Total Other Income/Expenses | -10.73M | 72.61M | 54.73M | -1.92M | 269.00K |
Income Before Tax | -110.78M | -11.97M | -26.48M | -66.52M | -85.42M |
Income Before Tax Ratio | 0.00% | -764.54% | -2,096.36% | -4,461.70% | -1,380.67% |
Income Tax Expense | 0.00 | -76.18M | -64.01M | 2.20M | 0.00 |
Net Income | -110.78M | 64.22M | 37.54M | -68.73M | -85.42M |
Net Income Ratio | 0.00% | 4,103.45% | 2,971.97% | -4,609.39% | -1,380.67% |
EPS | -1.07 | 0.62 | 0.94 | -5.52 | -4.25 |
EPS Diluted | -1.07 | 0.62 | 0.94 | -5.52 | -4.25 |
Weighted Avg Shares Out | 103.42M | 103.05M | 39.97M | 12.45M | 20.12M |
Weighted Avg Shares Out (Dil) | 103.42M | 103.05M | 39.97M | 12.45M | 20.12M |
Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.
Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination
EXCLUSIVE: Humacyte, Alpha Healthcare CEOs Talk SPAC Deal, Technology, Trials On 'SPACs Attack'
2 SPAC Stocks That Could Be 10-Baggers
Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021
Humacyte: Disrupting The Organ Transplant Industry
Regenerative Tissue Developer Humacyte Going Public Via SPAC
Source: https://incomestatements.info
Category: Stock Reports